Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Emergent Biosolutions Company Profile (NYSE:EBS)

Consensus Ratings for Emergent Biosolutions (NYSE:EBS) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $30.50 (39.21% upside)

Analysts' Ratings History for Emergent Biosolutions (NYSE:EBS)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/27/2014ZacksUpgradeNeutral -> Outperform$26.00ViewTweet This Rating  Share This Rating on StockTwits
8/12/2014ZacksReiterated RatingNeutral -> Neutral$25.00ViewTweet This Rating  Share This Rating on StockTwits
7/25/2014ZacksReiterated RatingNeutral -> Neutral$24.00ViewTweet This Rating  Share This Rating on StockTwits
5/15/2014Summer StreetInitiated CoverageBuy$35.00ViewTweet This Rating  Share This Rating on StockTwits
5/12/2014TheStreetDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
4/10/2013Janney Montgomery ScottInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
3/20/2013TheStreetDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
3/8/2013Cowen and CompanyReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
1/2/2013TheStreetUpgradeBuyViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/30/2012 forward)
Discuss Emergent Biosolutions